The switch from etanercept originator to SB4: data from a real-life experience on tolerability and persistence on treatment in joint inflammatory diseases.

Saved in:
Bibliographic Details
Title: The switch from etanercept originator to SB4: data from a real-life experience on tolerability and persistence on treatment in joint inflammatory diseases.
Authors: Bruni C; Department of Experimental and Clinical Medicine, Division of Rheumatology, University of Firenze, Via delle Oblate 4, 50141, Firenze, Italy., Gentileschi S; Department of Medical Sciences, Surgery and Neurosciences, Rheumatology Unit, University of Siena, Siena, Italy., Pacini G; Department Experimental and Clinical Medicine, Division of Rheumatology, University of Florence, Florence, Italy., Baldi C; Department of Medical Sciences, Surgery and Neurosciences, Rheumatology Unit, University of Siena, Siena, Italy., Capassoni M; Department Experimental and Clinical Medicine, Division of Rheumatology, University of Florence, Florence, Italy., Tofani L; Department Experimental and Clinical Medicine, Division of Rheumatology, University of Florence, Florence, Italy., Bardelli M; Department of Medical Sciences, Surgery and Neurosciences, Rheumatology Unit, University of Siena, Siena, Italy., Cometi L; Department Experimental and Clinical Medicine, Division of Rheumatology, University of Florence, Florence, Italy., Cantarini L; Department of Medical Sciences, Surgery and Neurosciences, Rheumatology Unit, University of Siena, Siena, Italy., Nacci F; Department Experimental and Clinical Medicine, Division of Rheumatology, University of Florence, Florence, Italy., Vietri M; Department Experimental and Clinical Medicine, University of Florence, Florence, Italy., Bartoli F; Department Geriatric Medicine, Division of Rheumatology, Azienda Ospedaliero Universitaria Careggi, Firenze, Italy., Fiori G; Department Geriatric Medicine, Division of Rheumatology, Azienda Ospedaliero Universitaria Careggi, Firenze, Italy., Frediani B; Department of Medical Sciences, Surgery and Neurosciences, Rheumatology Unit, University of Siena, Siena, Italy., Matucci-Cerinic M; Department Experimental and Clinical Medicine, Division of Rheumatology, University of Florence, Florence, Italy.
Source: Therapeutic advances in musculoskeletal disease [Ther Adv Musculoskelet Dis] 2020 Oct 13; Vol. 12, pp. 1759720X20964031. Date of Electronic Publication: 2020 Oct 13 (Print Publication: 2020).
Publication Type: Journal Article
Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101517322 Publication Model: eCollection Cited Medium: Print ISSN: 1759-720X (Print) Linking ISSN: 1759720X NLM ISO Abbreviation: Ther Adv Musculoskelet Dis Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1759-720X
DOI:10.1177/1759720X20964031